These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 9719471
21. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor. Kleniewski J, Donaldson VH. Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):198-202. PubMed ID: 8419923 [Abstract] [Full Text] [Related]
22. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Joseph K, Shibayama Y, Nakazawa Y, Peerschke EI, Ghebrehiwet B, Kaplan AP. Immunopharmacology; 1999 Sep 01; 43(2-3):203-10. PubMed ID: 10596854 [Abstract] [Full Text] [Related]
23. Bradykinin regulates the expression of kininogen binding sites on endothelial cells. Zini JM, Schmaier AH, Cines DB. Blood; 1993 Jun 01; 81(11):2936-46. PubMed ID: 8388750 [Abstract] [Full Text] [Related]
24. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease. Miyoshi S, Shinoda S. FEBS Lett; 1992 Aug 24; 308(3):315-9. PubMed ID: 1380471 [Abstract] [Full Text] [Related]
25. Identification of Human Kinin-Forming Enzyme Inhibitors from Medicinal Herbs. Madkhali H, Tarawneh A, Ali Z, Le HV, Cutler SJ, Khan IA, Shariat-Madar Z. Molecules; 2021 Jul 07; 26(14):. PubMed ID: 34299400 [Abstract] [Full Text] [Related]
26. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Shibayama Y, Joseph K, Nakazawa Y, Ghebreihiwet B, Peerschke EI, Kaplan AP. Clin Immunol; 1999 Jan 07; 90(1):89-99. PubMed ID: 9884356 [Abstract] [Full Text] [Related]
27. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor. Kaplan AP, Silverberg M, Dunn JT, Miller G. Ann N Y Acad Sci; 1981 Jan 07; 370():253-60. PubMed ID: 6455951 [Abstract] [Full Text] [Related]
28. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. Joseph K, Tholanikunnel BG, Bygum A, Ghebrehiwet B, Kaplan AP. J Allergy Clin Immunol; 2013 Aug 07; 132(2):470-5. PubMed ID: 23672780 [Abstract] [Full Text] [Related]
29. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Nakazawa Y, Joseph K, Kaplan AP. Int Immunopharmacol; 2002 Dec 07; 2(13-14):1875-85. PubMed ID: 12494915 [Abstract] [Full Text] [Related]
30. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Schousboe I. Eur J Biochem; 2003 Jan 07; 270(1):111-8. PubMed ID: 12492481 [Abstract] [Full Text] [Related]
31. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. Lenich C, Pannell R, Gurewich V. Thromb Haemost; 1995 Aug 07; 74(2):698-703. PubMed ID: 8585009 [Abstract] [Full Text] [Related]
32. Activation of the kinin-forming cascade on the surface of endothelial cells. Joseph K, Ghebrehiwet B, Kaplan AP. Biol Chem; 2001 Jan 07; 382(1):71-5. PubMed ID: 11258676 [Abstract] [Full Text] [Related]
33. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. Liu J, Qin J, Borodovsky A, Racie T, Castoreno A, Schlegel M, Maier MA, Zimmerman T, Fitzgerald K, Butler J, Akinc A. RNA; 2019 Feb 07; 25(2):255-263. PubMed ID: 30463937 [Abstract] [Full Text] [Related]
34. Identification and characterization of a new kallikrein-kinin system inhibitor from the salivary glands of the malaria vector mosquito Anopheles stephensi. Isawa H, Orito Y, Iwanaga S, Jingushi N, Morita A, Chinzei Y, Yuda M. Insect Biochem Mol Biol; 2007 May 07; 37(5):466-77. PubMed ID: 17456441 [Abstract] [Full Text] [Related]
35. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions. Shibayama Y, Brunnee T, Kaplan AP, Reddigari S. Braz J Med Biol Res; 1994 Aug 07; 27(8):1817-28. PubMed ID: 7749371 [Abstract] [Full Text] [Related]
36. Binding of activation of kinin-forming proteins on vascular endothelial cells. Kaplan AP, Joseph K, Shibayama Y. Immunopharmacology; 1997 Jun 07; 36(2-3):201-7. PubMed ID: 9228547 [No Abstract] [Full Text] [Related]
37. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP. Thromb Haemost; 2001 Jan 07; 85(1):119-24. PubMed ID: 11204562 [Abstract] [Full Text] [Related]
38. Factor XII does not initiate prekallikrein activation on endothelial cells. Røjkjaer R, Hasan AA, Motta G, Schousboe I, Schmaier AH. Thromb Haemost; 1998 Jul 07; 80(1):74-81. PubMed ID: 9684789 [Abstract] [Full Text] [Related]
39. Activation of the plasma kinin forming cascade along cell surfaces. Kaplan AP, Joseph K, Shibayama Y, Reddigari S, Ghebrehiwet B. Int Arch Allergy Immunol; 2001 Jul 07; 124(1-3):339-42. PubMed ID: 11307009 [Abstract] [Full Text] [Related]